NSE · NEULANDLAB
Neuland Laboratories Limited
₹23,320.00
+0.49%
Market Cap
30,083.97 Cr
P/E Ratio
82.20
P/B Ratio
16.05
ROE
19.42%
ROCE
23.11%
Dividend Yield
0.15%
52W High
₹23,650.00
52W Low
₹12,447.00
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 641.58 Cr | 776.25 Cr |
| Net Profit | 147.67 Cr | 212.67 Cr |
| EPS | 115.10 | 165.76 |
| Operating Profit | 204.82 Cr | 294.70 Cr |
Shareholding pattern
Promoter
32.62%
Public
67.38%
FII
—
DII
—
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 24 Jul 2026 | Dividend | Dividend - Rs 34 Per Share |
| 18 Jul 2025 | Dividend | Dividend - Rs 12 Per Share |
| 12 Jul 2024 | Dividend | Annual General Meeting/Dividend - Rs 14 Per Share |
| 11 Jul 2023 | Dividend | Annual General Meeting/Dividend - Rs 10 Per Share |
| 14 Jul 2022 | Dividend | Annual General Meeting/Dividend - Rs 5 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.